Daniel Weintraub Selected Research

Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)

1/2017	Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.
10/2016	Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
3/2015	Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
8/2014	Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
12/2013	Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?
1/2013	Impulse control and related disorders in Parkinson's disease.
2/2012	Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.
12/2010	Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
5/2010	Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
8/2009	Impulsive and compulsive behaviors in Parkinson's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Weintraub Research Topics

Disease

86	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2003
46	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2003
43	Dementia (Dementias) 01/2022 - 08/2003
42	Cognitive Dysfunction 01/2022 - 10/2006
14	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2017 - 07/2006
13	Psychotic Disorders (Schizoaffective Disorder) 06/2021 - 10/2006
7	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 01/2017
7	Atrophy 01/2022 - 12/2011
6	Hallucinations (Hallucination) 01/2022 - 05/2016
6	Disease Progression 01/2022 - 01/2015
6	Gambling (Pathological Gambling) 01/2020 - 05/2010
5	Synucleinopathies 01/2021 - 02/2013
5	Movement Disorders (Movement Disorder) 10/2020 - 01/2015
4	Tremor (Tremors) 01/2022 - 11/2013
4	Disorders of Excessive Somnolence (Hypersomnia) 01/2020 - 10/2011
3	Parkinsonian Disorders (Parkinsonism) 11/2021 - 07/2011
3	Constipation 01/2021 - 10/2011
3	REM Sleep Behavior Disorder 01/2021 - 07/2017
3	Anosmia 01/2018 - 09/2011
3	Prescription Drug Overuse 01/2017 - 01/2013
2	Lewy Body Disease (Lewy Body Dementia) 10/2020 - 01/2018
2	Mental Disorders (Mental Disorder) 10/2020 - 05/2016
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2019 - 10/2011
2	Frontotemporal Dementia (Semantic Dementia) 01/2018 - 11/2017
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 11/2017
2	Amyloid Plaque 01/2017 - 02/2013
2	Dizziness (Lightheadedness) 01/2016 - 04/2010
2	Fatigue 01/2015 - 10/2011
2	Depressive Disorder (Melancholia) 09/2003 - 08/2003
1	Melanoma (Melanoma, Malignant) 01/2022
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2021
1	Back Pain (Backache) 02/2021
1	Headache (Headaches) 01/2021
1	Sleep Wake Disorders 01/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2019
1	Hypokinesia (Bradykinesia) 12/2018

Drug/Important Bio-Agent (IBA)

41	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2011
17	Dopamine (Intropin)FDA LinkGeneric 02/2021 - 12/2007
15	Antidepressive Agents (Antidepressants)IBA 10/2020 - 09/2003
13	Amyloid (Amyloid Fibrils)IBA 01/2022 - 02/2013
13	Citalopram FDA LinkGeneric 05/2016 - 10/2011
11	Antipsychotic Agents (Antipsychotics)IBA 06/2021 - 10/2006
10	Apolipoproteins E (ApoE)IBA 01/2022 - 04/2012
10	Dopamine Agonists (Dopamine Agonist)IBA 10/2020 - 07/2006
9	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 02/2005
8	Levodopa (L Dopa)FDA LinkGeneric 11/2021 - 10/2006
7	Pharmaceutical PreparationsIBA 01/2021 - 12/2007
7	Sertraline (Zoloft)FDA LinkGeneric 01/2014 - 08/2003
6	Amyloid beta-PeptidesIBA 01/2022 - 01/2016
6	SynucleinsIBA 01/2019 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2011
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 09/2015
4	pimavanserinIBA 01/2021 - 02/2017
4	Quetiapine Fumarate (Seroquel)FDA Link 01/2020 - 10/2006
3	ApolipoproteinsIBA 01/2022 - 04/2012
3	Cholinergic Antagonists (Anticholinergics)IBA 11/2021 - 01/2019
3	Memantine (Namenda)FDA Link 03/2016 - 10/2011
3	Rivastigmine (Exelon)FDA LinkGeneric 06/2015 - 09/2011
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2011 - 01/2006
3	Olanzapine (Zyprexa)FDA Link 10/2011 - 12/2003
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2022 - 04/2012
2	alpha-SynucleinIBA 06/2022 - 01/2017
2	Hypnotics and Sedatives (Sedatives)IBA 01/2020 - 03/2016
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 01/2018
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020 - 06/2007
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2018
2	Leucine (L-Leucine)FDA Link 01/2020 - 01/2018
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 09/2015
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 04/2011
2	rasagiline (Azilect)FDA Link 01/2016 - 01/2015
2	Naltrexone (ReVia)FDA LinkGeneric 03/2015 - 08/2014
2	Clozapine (Clozaril)FDA LinkGeneric 10/2011 - 12/2003
2	Pramipexole (Mirapex)FDA LinkGeneric 10/2011 - 06/2010
2	Amantadine (Aman)FDA LinkGeneric 10/2011 - 12/2010
2	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2006 - 12/2003
1	AlbuminsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Muscarinic AntagonistsIBA 11/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 04/2021
1	Coal (Coals)IBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2019
1	EnzymesIBA 01/2019
1	Staphylococcal Protein A (Protein A)IBA 01/2019
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2019
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019
1	Prescription DrugsIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 11/2018
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2018
1	4-hexyloxyaniline (HOA)IBA 06/2018

Therapy/Procedure

17	Therapeutics 01/2022 - 12/2007
8	Activities of Daily Living (ADL) 01/2021 - 10/2008
5	Deep Brain Stimulation 12/2021 - 09/2005
2	Home Nursing (Nursing, Home) 01/2022 - 08/2003
1	Denervation 01/2021
1	Precision Medicine 01/2021
1	Inappropriate Prescribing 01/2019